Stewart L Greisman

Title: Stewart L Greisman: Innovator in Medical Diagnostics

Introduction

Stewart L Greisman is a notable inventor based in Littleton, CO (US). He has made significant contributions to the field of medical diagnostics, particularly in the detection of appendicitis. His innovative approach utilizes the measurement of a specific urinary pigment to identify this condition.

Latest Patents

Greisman's most recent patent focuses on the "Detection of appendicitis by measurement of uroerythrin." This patent outlines a method for detecting appendicitis by determining a threshold presence of the urinary pigment uroerythrin in the urine of individuals suspected of having the condition. The detection process involves the precipitation of a sediment that exhibits a pink to red color. Additionally, various qualitative, semiquantitative, or quantitative methods can be employed to measure uroerythrin levels, including HPLC, TLC, radioimmunoassay, colorimetric tests, NMR, mass spectrometry, electrophoresis, and monoclonal antibody tests.

Career Highlights

Greisman is associated with Appenditech, Inc., where he continues to advance his research and innovations in medical diagnostics. His work has the potential to improve the accuracy and efficiency of appendicitis detection, which is crucial for timely medical intervention.

Collaborations

Throughout his career, Greisman has collaborated with notable professionals in the field, including David Bar-Or and Jon G Kastendieck. These collaborations have likely contributed to the development and refinement of his innovative diagnostic methods.

Conclusion

Stewart L Greisman is a pioneering inventor whose work in the detection of appendicitis through the measurement of uroerythrin represents a significant advancement in medical diagnostics. His contributions continue to impact the field positively, enhancing patient care and outcomes.